Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma

SIMPLE SUMMARY: Despite crucial scientific advances, Glioblastoma (GB) remains a fatal disease with limited therapeutic options and a lack of suitable biomarkers. The unveiled competence of the brain immune system together with the breakthrough advent of immunotherapy has shifted the present transla...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzaschi, Giulia, Olivari, Alessandro, Pavarani, Antonio, Lagrasta, Costanza Anna Maria, Frati, Caterina, Madeddu, Denise, Lorusso, Bruno, Dallasta, Silvia, Tommasi, Chiara, Musolino, Antonino, Tiseo, Marcello, Michiara, Maria, Quaini, Federico, Crafa, Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265092/
https://www.ncbi.nlm.nih.gov/pubmed/35805021
http://dx.doi.org/10.3390/cancers14133249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265092/
https://www.ncbi.nlm.nih.gov/pubmed/35805021
http://dx.doi.org/10.3390/cancers14133249

Ejemplares similares